Psychiatric comorbidities among opioid-dependent patients attending department of psychiatry, regional institute of medical sciences hospital, Manipur

Mohanty, Rakesh; Senjam, Gojendra; Singh, Ningombam Heramani

doi:10.4103/ijsp.ijsp_102_17

Cited by 7 publications

(5 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionsupporting

confidence: 92%

“…In our study the results were in line with the demographic profile of predominant nuclear family, married and semiskilled population as prevalent in the available literature (Rather et al, 2013;Mohanty et al, 2018;Bashir et al, 2015). A study by, (Mohanty et al, 2018) in Manipur, it was found to have equal distribution of joint and nuclear families (Mohanty et al, 2018). Presence of personality disorder is comparable with the findings of an 11 years retrospective study by (Basu et al, 2013) where around 10% substance use disorder cases had personality disorder (Basu et al, 2013).…”

Section: Discussionsupporting

confidence: 92%

“…Among the opioid use disorder patients following up for opioid agonist treatment in Psychiatry OPD, around 32 individuals belonged to the geriatric population (age 60years and above). There was a predominance of male gender in our study population which is comparable to the available studies from states of Punjab and Kashmir about the profile of patients visiting de-addiction clinics (Rather et al, 2013;Mohanty et al, 2018;Farhat et al, 2015). This is also reflective of more promptness in male gender to seek help for substance use problems as compared to females in India.…”

Section: Discussionsupporting

confidence: 84%

“…; which may add to negative coping in form of substance use. Hence, there may be continuation of opioid use from adulthood, initiation or re-initiation of drug use in geriatric population (Mohanty et al, 2018).…”

Section: Abstract: Elderly Indian Population Opioid Use Disorder Bupr...mentioning

confidence: 99%

See 3 more Smart Citations

A Study of Clinical and Socio-Demographic Profile of Elderly Patients with Opioid Use Disorder on Agonist Treatment Attending a Tertiary Care Teaching Institute of India

2024

J Psychol Neurosci

View full text Add to dashboard Cite

Background: Opioid use is one among the major substance of use in Indian population which is not only seen in younger age group but rather is an upcoming concern in the elderly population as well. Opioid agonist treatment for opioid use disorder is a better way of management, among which buprenorphine is a safer option. Despite, being an important area of health concern, opioid use is poorly studied in the geriatric population. Objective: To study the clinical and socio-demographic profile of elderly patients with opioid use disorder on agonist treatment attending a tertiary care teaching institute of urban Delhi. Method: A retrospective study was done in an OPD based opioid treatment centre of a tertiary care hospital in Delhi to analyze the socio-demographic, clinical profile, pattern of opioid use disorder and opioid agonist treatment (Buprenorphine) in elderly Indian population over a year. The data collected was further analyzed for descriptive and analytic statistics using SPSS version 23.0. Results: A total of 32 subjects of age > 60years, with predominant male population having mean age of 63.6years we seen. They had heroin use by inhalation route as a major opioid use. The main source of referral was by friends and self with significant medical and psychiatric comorbidities that was seen in the elderly group. An average dose of 2.34mg of Buprenorphine was found to effectively manage the geriatric opioid use disorder. Conclusion: Opioid Used Disorder is common in Geriatric population and is often associated with both psychiatric and medical co-morbidities. Opioid agonist treatment is an effective approach in management of elderly cases of opioid use disorder. Declaration of Interest : None

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionsupporting

confidence: 92%

Section: Discussionsupporting

confidence: 84%

Section: Abstract: Elderly Indian Population Opioid Use Disorder Bupr...mentioning

confidence: 99%

See 2 more Smart Citations

A Study of Clinical and Socio-Demographic Profile of Elderly Patients with Opioid Use Disorder on Agonist Treatment Attending a Tertiary Care Teaching Institute of India

2024

J Psychol Neurosci

View full text Add to dashboard Cite

show abstract

“…In our study, psychiatric comorbidities were found in 88.1% of the participants. This is similar to findings in other studies conducted in other parts of India, such as those by Farooqui et al and Mohanty et al 29 , 30 , in which 98.6% and 77.5% of participants had psychiatric comorbidities, respectively. This difference in the prevalence can be explained by the difference in the measurement tools used in these studies.…”

Section: Discussionsupporting

confidence: 92%

Psychiatric comorbidities and concurrent substance use among people who inject drugs: a single-centre hospital-based study

Kar,

Gania,

Bandy

et al. 2023

Sci Rep

View full text Add to dashboard Cite

The management of people who inject drugs (PWID) is compounded by the presence of psychiatric comorbidities leading to frequent relapses and poor treatment outcomes. Early identification and treatment of psychiatric comorbidities should be included in the management to enhance treatment outcomes. The objective of this study was to estimate the prevalence of psychiatric comorbidities and concurrent substance use among opioid injectors. This hospital-based, cross-sectional study was conducted from March 2021 to August 2022. This study included opioid injectors of all ages and both sexes. The Mini International Neuropsychiatric Interview-7 (MINI-7) and WHO-ASSIST were used to determine psychiatric comorbidities and concurrent substance use, respectively. Both crude and adjusted odds ratios were calculated to assess associations among demographic variables, concurrent substance use and psychiatric comorbidities. Among the 328 opioid injectors, the overall prevalence of psychiatric comorbidities was 88.1%, with the majority (68.6%) having more than one comorbidity. The most common psychiatric comorbidities were panic disorder (41.2%), social anxiety disorder (40.5%), and antisocial personality disorder (39.3%). Concurrent use of alcoholic beverages doubled the risk of ASPD (odds ratio 2.14 (1.24–3.72)). Cocaine (odds ratio 2.36 (1.10–5.03)) and amphetamines (odds ratio 7.68 (2.21–26.65)) increased the risk of OCD. Daily heroin injections were negatively associated (odds ratio 0.18 (0.03–0.94)) with psychotic disorders. Younger age (adjusted odds ratio 0.20 (0.79–0.53)) and never married status (adjusted odds ratio 2.62 (1.06–6.47)) were the only significant variables in the regression analysis. In conclusion, opioid injectors had a higher prevalence of numerous psychiatric comorbidities. The most common comorbidity was anxiety disorders. Concurrent use of tobacco, cannabis, cocaine, inhalants, etc., greatly increased the risk of psychiatric comorbidities.

show abstract

Untangling the Complexities of Substance Use Initiation and Recovery: Client Reflections on Opioid Use Prevention and Recovery From a Social-Ecological Perspective

2021

View full text Add to dashboard Cite

Background: In Canada, the rate of opioid use, opioid use disorder (OUD), and associated mortality and morbidity are higher among Indigenous Peoples than the general population. Indigenous Peoples on medications for opioid use disorders (MOUD) often face distinct barriers that hinder their clinical progress, leading to treatment attrition. Methods: We used a social-ecological model to inquire into clients’ experiences with a history of treatment failure for OUD. We used exploratory qualitative research to engage 22 clients with a history of OUD treatment dropouts and who are currently on MOUD. In-depth, semi-structured interviews lasting an average of 30 minutes were conducted on-site. Results: We identified 4 themes from the study: (a) risk for substance use; (b) factors sustaining substance use; (c) factors leading to treatment, and (d) treatment failure and re-enrollment. Conclusion: Using a socio-ecological model helps to understand factors that influence an individual’s risk for OUD, decision to pursue treatment, and treatment outcomes. Furthermore, social ecological model also creates possibilities to develop supportive, multilevel interventions to prevent OUD risks and support for clients on MOUD. Such interventions include mitigating adverse childhood experiences, supporting families, and creating safe community environments.

show abstract

Psychiatric comorbidities among opioid-dependent patients attending department of psychiatry, regional institute of medical sciences hospital, Manipur

Cited by 7 publications

References 8 publications

A Study of Clinical and Socio-Demographic Profile of Elderly Patients with Opioid Use Disorder on Agonist Treatment Attending a Tertiary Care Teaching Institute of India

A Study of Clinical and Socio-Demographic Profile of Elderly Patients with Opioid Use Disorder on Agonist Treatment Attending a Tertiary Care Teaching Institute of India

Psychiatric comorbidities and concurrent substance use among people who inject drugs: a single-centre hospital-based study

Untangling the Complexities of Substance Use Initiation and Recovery: Client Reflections on Opioid Use Prevention and Recovery From a Social-Ecological Perspective

Contact Info

Product

Resources

About